Ruminants

CattleGoatsSheep
The trademarks indicated by CAPITAL LETTERS in this publication are the property of, licensed to, promoted or distributed by Schering-Plough Corporation, its subsidiaries or related companies. As used in this publication, the terms “Schering-Plough” and the “company” refer collectively to Schering-Plough Corporation, the publicly held parent company, and its domestic and international subsidiaries, which are engaged in the discovery, development, manufacturing and marketing of pharmaceutical, animal health and consumer products worldwide.

Bovine Reproduction Congress in Colombia

Intervet/Schering-Plough Animal Health recently organized the Second International Congress of Bovine Reproduction in Bogotá, Colombia. The event was held mid September and attracted both local and international speakers and an audience of more than 500 veterinarians.

One of the keynote speakers was Dr. Gerhardt Schuring, Dean of Veterinary Medicine at the Virginia Polytechnic Institute and State University in the U.S. and inventor of the RB51 vaccine, who gave a highly informative presentation on Brucella Abortus (also known as undulant fever).

There were also lively discussions — with speakers from Mexico, Brazil and Venezuela — on biotechnology’s role in improving reproduction on already productive farms. Overall, the congress was regarded as a great success by all present. The subjects addressed and the discussions that followed were highly valuable and provided real solutions for reproductive problems on the Colombian farms.

IMG_BovCongres1IMG_BovCongres2